Healthcare -
Biotechnology - NASDAQ - US
$ 33.91
0.653 %
$ 3.78 B
Market Cap
-36.07
P/E
VKTX - CASH & EQUIVALENTS
Cash & Equivalents VKTX - Viking Therapeutics, Inc.
55.5 M
LAST VALUE
45.09%
2 YEAR CAGR
17.51%
5 YEAR CAGR
77.42%
10 YEAR CAGR